|
|
|
| Efficacy of combined antihypertension and cholesterol lowering treatment on atherosclerosis in patients with essential hypertension |
| MIAO Huining1, JIA Xinwei2, ZHANG Hong2, SONG Xuena3, CAO Yafeng4, LI Dandan4, LIU Chunxia4, YAN Zhenfeng4, LIU Qian5, WANG Yushui5 |
1. Department of Business, Baoding Local Blood Center, Hebei Province, Baoding 071051, China;
2. Department of Cardiology, Affillated Hospital of Hebei University, Baoding 071000, China;
3. Department of Cardiology, Baoding First Center Hospital, Hebei Province, Baoding 071000, China;
4. Department of Cardiology, Mancheng People’s Hospital, Hebei Province, Mancheng 072150, China;
5. Department of Cardiology, Gaobeidian People’s Hospital, Hebei Province, Gaobeidian 074000, China |
|
|
|
|
Abstract Objective To evaluate the efficacy of combined antihypertension and cholesterol lowering treatment on atherosclerosis in patients with essential hypertension.Methods 120 patients with high blood pressure were recruited from June 2012 to June 2013 in the Affillated Hospital of Hebei University. By carotid ultrasound examination, all patients showed carotid IMT thickening (IMT value≥0.9 mm), 120 patients were randomly divided into 2 groups by the double blind method. Control group consisted of 60 patients in health education, on regimen of low salt, low fat diet, quitting smoking and smoking were given benazepril orally (10 mg/d, QD). Study group (60 cases, on the basis of the medicament in control group, were given rosuva statin orally (10 mg/d, QN). Treatments lasted for 8 weeks, the blood pressure, IMT and blood fat in the two groups were recorded before and after treatment, and compared between the two groups, and statistical analysis was conducted. Results Before the treatment, the control group showed IMT values (1.05±0.32)mm, the study group (1.06±0.29) mm; after treatment, the control group showed IMT (0.89±0.17) mm, the treatment group (0.58±0.19) mm. Compared with before treatment, IMT were reduced after treatment in both groups, differences were statistically significant (P<0.05). Blood pressure significantly decreased after treatment, with statistically significant difference(P<0.05), but comparison between the two groups had no statistical difference. Blood lipid levels in the control group before and after treatment were not statistically different (P<0.05), the study group showed compared with before treatment, the blood lipid level declined obviously, with statistically significant difference (P<0.05). Compared with the control group after treatment, the study group showed lipid levels dropped significantly after treatment, with statistically significant difference(P<0.05). Conclusions Benazeprilin combined with rosuvastatin in patients with hypertension has good reversal effect on carotid IMT, which can delay the progress of atherosclerosis.
|
|
Received: 08 November 2014
|
|
|
|
|
|
| [1] |
方为公,时淑华.原发性高血压的水平与辛伐他汀干预的影响[J].现代预防医学,2011,38(14):2566-2567.
|
| [6] |
胡大一, 向小平. 动脉粥样硬化早期检测的临床应用—大动脉僵硬度(弹性)和功能检查[J]. 中国心血管病研究杂志,2007,5(2): 81-82.
|
| [2] |
殷 瑛,任 杰,赵兴胜. 高血压与血脂异常对亚临床动脉粥样硬化病变影响的研究进展[J].医学综述,2009,15(7):1060-1061.
|
| [3] |
陈 玲,林桂花. 高血压病患者调脂联合降压治疗的临床疗效分析[J].中国医师杂志,2008,10(5): 690-691.
|
| [7] |
蒋艺兰. 2型糖尿病患者颈动脉内膜中层厚度及血清超敏C反应蛋白的测定及其意义[J]. 南通大学学报(医学版), 2010, 30(5):379-380.
|
| [4] |
张建立,张环宇,倪秋杰,等.超声对高血压患者颈动脉内膜-中层厚度及血管顺应性研究[J]. 中国超声诊断学杂志,2003,4(2): 84-86.
|
| [8] |
范晓红,王 春.颈动脉粥样硬化的发病情况及其影响因素的调查与相关分析[J]. 中华心血管病杂志, 2006, 34(2): 174-175.
|
| [5] |
中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011, 19(8):701-703.
|
| [9] |
Polak J F,Pencina M J,Karol A M,et al. Associations of Carotidaltery Intima-media Thickness(IMT) with risk factors and prevalent cardiovascular disease: comparison of mean common carotidartery IMT with maximum internal carotid artery IMT[J].Ultrasound Med,2010,29(12):1759-1768.
|
| [10] |
简政威,赵洪磊.不同血压分级患者同型半胱氨酸水平与颈动脉内膜中层厚度的关系[J].广东医学,2013,34(5):752-753.
|
| [6] |
胡大一, 向小平. 动脉粥样硬化早期检测的临床应用—大动脉僵硬度(弹性)和功能检查[J]. 中国心血管病研究杂志,2007,5(2): 81-82.
|
| [11] |
Nissen S E, Nicholls S J, Sipahi I, et al. Effect of very high-intensity station therapy on regression of coronary atherosclerosis: the ASTEROID trial[J]. JAMA, 2006, 295: 1556-1565.
|
| [7] |
蒋艺兰. 2型糖尿病患者颈动脉内膜中层厚度及血清超敏C反应蛋白的测定及其意义[J]. 南通大学学报(医学版), 2010, 30(5):379-380.
|
| [8] |
范晓红,王 春.颈动脉粥样硬化的发病情况及其影响因素的调查与相关分析[J]. 中华心血管病杂志, 2006, 34(2): 174-175.
|
| [9] |
Polak J F,Pencina M J,Karol A M,et al. Associations of Carotidaltery Intima-media Thickness(IMT) with risk factors and prevalent cardiovascular disease: comparison of mean common carotidartery IMT with maximum internal carotid artery IMT[J].Ultrasound Med,2010,29(12):1759-1768.
|
| [12] |
李增南,袁 东,岳海燕,等. 瑞舒伐他汀联合贝那普利对轻、中度高血压患者颈动脉内膜中层厚度的影响[J]. 南通大学学报(医学版),2011,31(6): 488-489.
|
| [13] |
魏 颖.高血压病药物治疗的方法及其原则[J].亚太传统医药,2011,7(11):58-59.
|
| [10] |
简政威,赵洪磊.不同血压分级患者同型半胱氨酸水平与颈动脉内膜中层厚度的关系[J].广东医学,2013,34(5):752-753.
|
| [11] |
Nissen S E, Nicholls S J, Sipahi I, et al. Effect of very high-intensity station therapy on regression of coronary atherosclerosis: the ASTEROID trial[J]. JAMA, 2006, 295: 1556-1565.
|
| [12] |
李增南,袁 东,岳海燕,等. 瑞舒伐他汀联合贝那普利对轻、中度高血压患者颈动脉内膜中层厚度的影响[J]. 南通大学学报(医学版),2011,31(6): 488-489.
|
| [13] |
魏 颖.高血压病药物治疗的方法及其原则[J].亚太传统医药,2011,7(11):58-59.
|
|
|
|
2015, Vol. 26 
